Anzeige
Mehr »
Samstag, 07.06.2025 - Börsentäglich über 12.000 News
Starke Zahlen: EBITDA bei 9 Mio.?€ - Startet jetzt die Neubewertung?
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A1J68D | ISIN: CNE100001M79 | Ticker-Symbol: 08HH
Tradegate
04.06.25 | 16:48
1,800 Euro
-3,38 % -0,063
Branche
Pharma
Aktienmarkt
ASIEN
1-Jahres-Chart
SHANGHAI FOSUN PHARMACEUTICAL GROUP CO LTD Chart 1 Jahr
5-Tage-Chart
SHANGHAI FOSUN PHARMACEUTICAL GROUP CO LTD 5-Tage-Chart
RealtimeGeldBriefZeit
1,7971,94406.06.
1,8141,91206.06.

Aktuelle News zur SHANGHAI FOSUN PHARMACEUTICAL Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
FrFOSUN PHARMA (02196): ANNOUNCEMENT REGARDING ELECTION OF EMPLOYEE DIRECTOR1
FrFOSUN PHARMA (02196): ARTICLES OF ASSOCIATION1
FrFOSUN PHARMA (02196): ANNOUNCEMENT - CHANGES TO THE REGISTERED CAPITAL AND ARTICLES OF ASSOCIATION1
FrFOSUN PHARMA Repurchases 800K A-Shrs, Involving ~RMB20M5
FrFOSUN PHARMA (02196): NEXT DAY DISCLOSURE RETURN - SHARE BUYBACK1
30.05.FOSUN PHARMA (02196): OVERSEAS REGULATORY ANNOUNCEMENT - ANNOUNCEMENT IN RELATION TO THE PROGRESS OF DRUG CLINICAL TRIAL BY A SUBSIDIARY5
30.05.FOSUN PHARMA Once Surges 10%+; Subsidiary's Luvometinib Tablets Receives Drug Registration Approval9
SHANGHAI FOSUN PHARMACEUTICAL Aktie jetzt für 0€ handeln
29.05.FOSUN PHARMA (02196): OVERSEAS REGULATORY ANNOUNCEMENT - ANNOUNCEMENT IN RELATION TO THE APPROVAL FOR DRUG REGISTRATION OF A SUBSIDIARY3
29.05.FOSUN PHARMA (02196): NEXT DAY DISCLOSURE RETURN - SHARE BUYBACK3
20.05.FOSUN PHARMA (02196): NOTIFICATION LETTER AND REQUEST FORM TO NON-REGISTERED SHAREHOLDERS5
20.05.FOSUN PHARMA (02196): NOTIFICATION LETTER AND REPLY FORM TO REGISTERED SHAREHOLDERS3
20.05.FOSUN PHARMA (02196): FORM OF PROXY FOR HOLDERS OF H SHARES FOR THE 2025 FIRST CLASS MEETING OF HOLDERS OF H SHARES TO BE HELD ON TUESDAY, 24 JUNE 20253
20.05.FOSUN PHARMA (02196): FORM OF PROXY FOR HOLDERS OF H SHARES FOR THE ANNUAL GENERAL MEETING TO BE HELD ON TUESDAY, 24 JUNE 20253
20.05.FOSUN PHARMA (02196): NOTICE OF 2025 FIRST H SHAREHOLDERS CLASS MEETING3
20.05.FOSUN PHARMA (02196): NOTICE OF ANNUAL GENERAL MEETING12
20.05.FOSUN PHARMA (02196): ANNUAL GENERAL MEETING; GRANT OF GENERAL MANDATE TO REGISTER AND ISSUE CORPORATE BONDS; RENEWED AND ADDITIONAL GUARANTEE QUOTA; ...1
12.05.FOSUN PHARMA (02196): OVERSEAS REGULATORY ANNOUNCEMENT - ANNOUNCEMENT REGARDING THE BREAKTHROUGH THERAPY DESIGNATION GRANTED TO PHARMACEUTICAL PRODUCT ...6
09.05.FOSUN PHARMA (02196): OVERSEAS REGULATORY ANNOUNCEMENT - ANNOUNCEMENT IN RELATION TO THE APPROVAL OF US FDA FOR DRUG CLINICAL TRIAL OF A SUBSIDIARY3
30.04.FOSUN PHARMA (02196): NEXT DAY DISCLOSURE RETURN - SHARE BUYBACK2
29.04.FOSUN PHARMA (02196): CONNECTED TRANSACTION - ESTABLISHMENT OF TARGET FUND2
Weiter >>
78 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1